Diagnostic and prognostic values of FDG-PET in patients with non-small cell lung cancer.
OBJECTIVE
The aim of this study was to address the efficacy of 2-[F-18]-Fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the staging of non-small cell lung cancer (NSCLC) and in prognostic prediction in patients with NSCLC.


METHODS
Forty-four patients (26 males, 18 females) were analyzed.


RESULTS
Accurate staging was obtained by addition of FDG-PET. Multivariate analysis indicated that the standardized uptake value of the primary tumor was the most significant prognostic factor for disease-free survival (P=.0073).


CONCLUSIONS
FDG-PET is useful for the diagnosis of NSCLC and for prognostic prediction in patients with NSCLC.
Abe
Koichiro
K
Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan. k-abe@radiol.med.kyushu-u.ac.jp
Baba
Shingo
S
Kaneko
Koichiro
K
Isoda
Takuro
T
Yabuuchi
Hidetake
H
Sasaki
Masayuki
M
Sakai
Shuji
S
Yoshino
Ichiro
I
Honda
Hiroshi
H
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002289:Carcinoma, Non-Small-Cell Lung / Q000000981:diagnostic imaging* / Q000473:pathology; D018572:Disease-Free Survival; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D011379:Prognosis; D019275:Radiopharmaceuticals
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18